Zalutumumab in Non-curable Patients With SCCHN

Clinical trial NCT00542308 · COMPLETED

Trial details

NCT number: NCT00542308
Sponsor: Genmab
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Cancer

Start date: 2008-01-01
Primary completion: 2011-08-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.